skip to content

Broker Views

Broker Forecast - Barclays Capital issues a broker note on Hikma Pharmaceuticals PLC

25 August 2017 08:00

Barclays Capital today reaffirms its overweight investment rating on Hikma Pharmaceuticals PLC (LON:HIK) and cut its price target to 1500p (from 2200p).

Story provided by StockMarketWire.com

Related Company: HIK

Info Point:

To buy or sell shares call our Dealing Room on 0113 243 6941.

Too much jargon? Our glossary will help make sense of things.

Find out more about our Share Dealing Services.

Client Area Access

» Secure Login

» Not registered yet?

Bluezest Aviva Aberdeen

Branch Finder

Redmayne-Bentley have High Street branches throughout the UK. Find your nearest branch.